Patients with moderate-to-severe atopic dermatitis maintain stable response with no or minimal fluctuations with 1 year of lebrikizumab treatment

to connected objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: Dermatology and Therapy, 14, 8, S. 2249-2260

Event
Veröffentlichung
(where)
Augsburg
(who)
Universität Augsburg
(when)
2024
Event
Veröffentlichung
(who)
Springer Science and Business Media LLC
(when)
2024
Creator
Silverberg, Jonathan I.
Wollenberg, Andreas
Stein Gold, Linda
Del Rosso, James
Yosipovitch, Gil
Lio, Peter
Carrascosa, Jose-Manuel
Gallo, Gaia
Ding, Yuxin
Xu, Zhenhui
Casillas, Marta
Pierce, Evangeline
Agell, Helena
Ständer, Sonja

DOI
10.1007/s13555-024-01226-9
URN
urn:nbn:de:bvb:384-opus4-1155456
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:43 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Silverberg, Jonathan I.
  • Wollenberg, Andreas
  • Stein Gold, Linda
  • Del Rosso, James
  • Yosipovitch, Gil
  • Lio, Peter
  • Carrascosa, Jose-Manuel
  • Gallo, Gaia
  • Ding, Yuxin
  • Xu, Zhenhui
  • Casillas, Marta
  • Pierce, Evangeline
  • Agell, Helena
  • Ständer, Sonja
  • Universität Augsburg
  • Springer Science and Business Media LLC

Time of origin

  • 2024

Other Objects (12)

Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis

Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis

Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis

Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis

Efficacy of docosahexaenoic acid in patients with atopic dermatitis

Hochschulschrift

Efficacy of docosahexaenoic acid in patients with atopic dermatitis

Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies

Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies

Aggregate response benefit in skin clearance and itch reduction with upadacitinib or dupilumab in patients with moderate-to-severe atopic dermatitis

Aggregate response benefit in skin clearance and itch reduction with upadacitinib or dupilumab in patients with moderate-to-severe atopic dermatitis

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

Brain Processing of Contagious Itch in Patients with Atopic Dermatitis

Brain Processing of Contagious Itch in Patients with Atopic Dermatitis

Patient-reported burden in adults with atopic dermatitis: an international qualitative study

Patient-reported burden in adults with atopic dermatitis: an international qualitative study

More time spent with clear skin and no itch with upadacitinib versus dupilumab for atopic dermatitis

More time spent with clear skin and no itch with upadacitinib versus dupilumab for atopic dermatitis

Study of the efficacy of a new topical skin formulation rich in antioxidants in patients with mild to moderate atopic dermatitis

Study of the efficacy of a new topical skin formulation rich in antioxidants in patients with mild to moderate atopic dermatitis

Atopic dermatitis: factors associated with age of onset in adulthood versus childhood [Abstract]

Atopic dermatitis: factors associated with age of onset in adulthood versus childhood [Abstract]

Skin microbiome and its association with host cofactors in determining atopic dermatitis severity

Skin microbiome and its association with host cofactors in determining atopic dermatitis severity

Related objects